BACKGROUND: There is considerable variation in progressive brain volume changes in schizophrenia. Whether this is related to the clinical heterogeneity that characterizes the illness remains to be determined. This study examines the relationship between change in brain volume over time and individual variation in psychopathology, as measured by five continuous symptom dimensions (i.e. negative, positive, disorganization, mania and depression). METHODS: Global brain volume measurements from 105 schizophrenia patients and 100 healthy comparison subjects, obtained at inclusion and 5-year follow-up, were used in this study. Symptom dimension scores were calculated by factor analysis of clinical symptoms. Using linear regression analyses and independent-samples t-tests, the relationship between symptom dimensions and progressive brain volume changes, corrected for age, gender and intracranial volume, was examined. Antipsychotic medication, outcome and IQ were investigated as potential confounders. RESULTS: In patients, the disorganization dimension was associated with change in total brain (β=-0.295, p=0.003) and cerebellar (β=-0.349, p<0.001) volume. Furthermore, higher levels of disorganization were associated with lower IQ, irrespective of psychiatric status (i.e. patient or control). In healthy comparison subjects, disorganization score was not associated with progressive brain volume changes. CONCLUSION: Heterogeneity in progressive brain volume changes in schizophrenia is particularly associated with variation in disorganization. Schizophrenia patients with high levels of disorganization exhibit more progressive decrease of global brain volumes and have lower total IQ. We propose that these patients form a phenotypically and biologically homogenous subgroup that may be useful for etiological (e.g., genetic) studies.
BACKGROUND: There is considerable variation in progressive brain volume changes in schizophrenia. Whether this is related to the clinical heterogeneity that characterizes the illness remains to be determined. This study examines the relationship between change in brain volume over time and individual variation in psychopathology, as measured by five continuous symptom dimensions (i.e. negative, positive, disorganization, mania and depression). METHODS: Global brain volume measurements from 105 schizophreniapatients and 100 healthy comparison subjects, obtained at inclusion and 5-year follow-up, were used in this study. Symptom dimension scores were calculated by factor analysis of clinical symptoms. Using linear regression analyses and independent-samples t-tests, the relationship between symptom dimensions and progressive brain volume changes, corrected for age, gender and intracranial volume, was examined. Antipsychotic medication, outcome and IQ were investigated as potential confounders. RESULTS: In patients, the disorganization dimension was associated with change in total brain (β=-0.295, p=0.003) and cerebellar (β=-0.349, p<0.001) volume. Furthermore, higher levels of disorganization were associated with lower IQ, irrespective of psychiatric status (i.e. patient or control). In healthy comparison subjects, disorganization score was not associated with progressive brain volume changes. CONCLUSION: Heterogeneity in progressive brain volume changes in schizophrenia is particularly associated with variation in disorganization. Schizophreniapatients with high levels of disorganization exhibit more progressive decrease of global brain volumes and have lower total IQ. We propose that these patients form a phenotypically and biologically homogenous subgroup that may be useful for etiological (e.g., genetic) studies.
Authors: Kirsten E S Craddock; Xueping Zhou; Siyuan Liu; Peter Gochman; Dwight Dickinson; Judith L Rapoport Journal: Schizophr Res Date: 2017-11-13 Impact factor: 4.939
Authors: Frederike Stein; Tina Meller; Katharina Brosch; Simon Schmitt; Kai Ringwald; Julia Katharina Pfarr; Susanne Meinert; Katharina Thiel; Hannah Lemke; Lena Waltemate; Dominik Grotegerd; Nils Opel; Andreas Jansen; Igor Nenadić; Udo Dannlowski; Axel Krug; Tilo Kircher Journal: Schizophr Bull Date: 2021-10-21 Impact factor: 9.306
Authors: Valerie M Anderson; Meghan E Goldstein; Robert R Kydd; Bruce R Russell Journal: Int J Neuropsychopharmacol Date: 2015-02-25 Impact factor: 5.176
Authors: Henriette D Heering; Godefridus J C Koevoets; Laura Koenders; Marise W J Machielsen; Carin J Meijer; Manabu Kubota; Jessica de Nijs; Wiepke Cahn; Hilleke E Hulshoff Pol; Lieuwe de Haan; Rene S Kahn; Neeltje E M van Haren Journal: Front Psychiatry Date: 2015-07-29 Impact factor: 4.157
Authors: P Fusar-Poli; R Smieskova; M J Kempton; B C Ho; N C Andreasen; S Borgwardt Journal: Neurosci Biobehav Rev Date: 2013-06-14 Impact factor: 8.989
Authors: Anna Comparelli; Antonella De Carolis; Valentina Corigliano; Giada Trovini; Julia Dehning; Simone Di Pietro; Eleonora De Pisa; Silvana Galderisi; Paolo Girardi Journal: Schizophr Res Cogn Date: 2014-08-30